Amicus Therapeutics to Present at the BTIG Virtual Biotechnology Conference
August 04 2020 - 7:00AM
Amicus Therapeutics (Nasdaq: FOLD) today announced that members of
the Amicus senior leadership team will participate in a fireside
chat at the BTIG Virtual Biotechnology Conference on Tuesday,
August 11, 2020 at 9:00 a.m. E.T.
A live audio webcast of the presentation can
also be accessed via the investors section of the Amicus
Therapeutics corporate website at
https://ir.amicusrx.com/events-and-presentations.
About Amicus Therapeutics
Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated
biotechnology company focused on discovering, developing and
delivering novel high-quality medicines for people living with rare
metabolic diseases. With extraordinary patient focus, Amicus
Therapeutics is committed to advancing and expanding a robust
pipeline of cutting-edge, first- or best-in-class medicines for
rare metabolic diseases. For more information please visit the
company’s website at www.amicusrx.com, and follow on Twitter and
LinkedIn.
CONTACT:
Investors:Amicus TherapeuticsAndrew
FaughnanDirector, Investor Relationsafaughnan@amicusrx.com (609)
662-3809
FOLD–G
Amicus Therapeutics (NASDAQ:FOLD)
Historical Stock Chart
From Aug 2024 to Sep 2024
Amicus Therapeutics (NASDAQ:FOLD)
Historical Stock Chart
From Sep 2023 to Sep 2024